Suchergebnisse - "Lorusso, Domenica"

PubPharm (459)

1

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

enthalten in: Leukemia | 2024

von Arends, C. | Kopp, K. | Hablesreiter, R. | +18

2

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18) : a randomised, double-blind, phase 3 clinical trial

enthalten in: Lancet (London, England) | 2024

von Lorusso, D. | Xiang, Y. | Hasegawa, K. | +32

3

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

enthalten in: Cancer treatment reviews | 2024

von Bartoletti, M. | Montico, M. | Lorusso, D. | +6

4

Best original research presented at the 24th European Congress on Gynaecological Oncology-Best of ESGO 2023

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Kacperczyk-Bartnik, J. | Bizzarri, N. | Zwimpfer, T. | +11

5

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

6

Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy

enthalten in: Advances in therapy | 2024

von Rognoni, C. | Lorusso, D. | Costa, F. | +1

7

Alpelisib for PIK3CA-mutated advanced gynecological cancers : First clues of clinical activity

enthalten in: Gynecologic oncology | 2024

von Passarelli, A. | Carbone, V. | Pignata, S. | +21

8

Progression-free survival and safety at 3.5 years of follow-up : results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary

enthalten in: Future oncology (London, England) | 2024

von González-Martín, A. | Pothuri, B. | Vergote, I. | +15

9

Reply to P.-H. Luo et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Monk, B. | Colombo, N. | Tewari, K. | +3

10

Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy

enthalten in: Advances in therapy | 2024

von Rognoni, C. | Lorusso, D. | Costa, F. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[46]